Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB Cause Myocardial infarction? 647 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 647 reports of Myocardial infarction have been filed in association with INFLIXIMAB (Renflexis). This represents 0.5% of all adverse event reports for INFLIXIMAB.

647
Reports of Myocardial infarction with INFLIXIMAB
0.5%
of all INFLIXIMAB reports
124
Deaths
379
Hospitalizations

How Dangerous Is Myocardial infarction From INFLIXIMAB?

Of the 647 reports, 124 (19.2%) resulted in death, 379 (58.6%) required hospitalization, and 185 (28.6%) were considered life-threatening.

Is Myocardial infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 647 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB Cause?

Off label use (34,801) Drug ineffective (33,738) Condition aggravated (16,616) Rheumatoid arthritis (16,251) Pain (15,061) Fatigue (13,473) Arthralgia (13,441) Infusion related reaction (12,946) Product use issue (12,752) Drug intolerance (11,173)

What Other Drugs Cause Myocardial infarction?

ROSIGLITAZONE (17,018) TESTOSTERONE (3,396) ADALIMUMAB (3,214) SACUBITRIL\VALSARTAN (3,120) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391) APIXABAN (2,010) TICAGRELOR (1,749) LENALIDOMIDE (1,712) ETANERCEPT (1,693) METFORMIN\ROSIGLITAZONE (1,640)

Which INFLIXIMAB Alternatives Have Lower Myocardial infarction Risk?

INFLIXIMAB vs INFLIXIMAB-ABDA INFLIXIMAB vs INFLIXIMAB-AXXQ INFLIXIMAB vs INFLIXIMAB-DYYB INFLIXIMAB vs INFLIXIMAB-QBTX INFLIXIMAB vs INFLIXIMAB, RECOMBINANT

Related Pages

INFLIXIMAB Full Profile All Myocardial infarction Reports All Drugs Causing Myocardial infarction INFLIXIMAB Demographics